Extend Biosciences Inc. is a start-up biotechnology company developing novel drug delivery formulations that improve the pharmacokinetic properties of peptides and proteins.

Peptides have been particularly challenging to bring to market because they are removed from circulation prior to administering therapeutic value.

Our proprietary platform technology significantly improves the circulating half-life and bioavailability of peptides, enabling the scientific community to truly develop potent and specific peptide-based drugs.

Our mission is to revolutionize drug delivery and give patients a better quality of life.

Follow us on Twitter: @extendbio